Vytala

📍 Malvern, United States🗓 Founded 2022👥 17 employees💰 Last funded Nov 2025
Biotechnology Research🌐 vytalahealth.com
Website LinkedIn
Vytala is a US-based food technology company, where heart, hope, and science meet to transform lives. Founded with a deep sense of purpose, we’re committed to changing how people use food as medicine. By advancing nutrition, it’s our aim to end nutrient deficiencies, starting with fat malabsorption. Gastrointestinal (GI) disease impacts 1 in 5 Americans, with 2 out of 3 experiencing GI symptoms, burdening the healthcare system with billions in costs. Fat malabsorption, a major contributor to digestive issues, can lead to severe developmental problems in children and chronic malnutrition in adults. Our proprietary lipid technology is clinically proven to enhance fat and nutrient absorption, optimizing weight gain, height growth, and overall health. Our first product is classified as a medical food and is eligible for CMS reimbursement. Join us on our mission to help people achieve their best health through the power of nutrition. Visit VytalaHealth.com to learn more.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Vytala?
Vytala has 1 investors on record on gritt.io, 1 mid-stage.
When did Vytala last raise funding?
The most recent investment in Vytala recorded on gritt.io was in November 2025.
When was Vytala founded?
Vytala was founded in 2022.
What industry is Vytala in?
Vytala operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vytala based?
Vytala is headquartered in Malvern, United States.